Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Cyclosporine in heart and heart-lung transplantation
D. L. Modry
, P. E. Oyer
, S. W. Jamieson
, E. B. Stinson
, J. C. Baldwin
, B. A. Reitz
, K. D. Dawkins
,
C. G. McGregor
, S. A. Hunt
, M. Moran
Research output
:
Contribution to journal
›
Article
›
peer-review
35
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cyclosporine in heart and heart-lung transplantation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cyclosporine
100%
Heart-lung Transplantation
100%
Immunosuppression
28%
Prednisone
14%
Hypertension
14%
Acute Rejection
14%
Heart Transplant
14%
Heart Transplant Recipients
14%
Postoperative Complications
14%
University Medical Centre
14%
Bronchiolitis Obliterans
14%
Intensive Care Unit
14%
Immunosuppressive Regimens
14%
Improved Survival
14%
Antithymocyte Globulin
14%
Survival Rate
14%
1-year Mortality
14%
3-year Survival
14%
Cellular Rejection
14%
Hospital Costs
14%
Stanford University
14%
Heart Allograft
14%
Humoral Rejection
14%
Renal Dysfunction
14%
Total Hospital Stay
14%
Medicine and Dentistry
Cyclosporine
100%
Heart Lung Transplantation
100%
Heart Graft
28%
Immunosuppressive Treatment
28%
Azathioprine
28%
Infection
14%
Atherosclerosis
14%
Bronchiolitis Obliterans
14%
Intensive Care Unit
14%
Postoperative Complication
14%
Heart Transplantation
14%
Acute Graft Rejection
14%
Survival Rate
14%
Thymocyte Antibody
14%
Cellular Rejection
14%
Hospital Cost
14%
Humoral Rejection
14%
Prednisone
14%
Immunosuppressive Drug
14%
Hypertension
14%
Immunology and Microbiology
Ciclosporin
100%
Lung Transplantation
100%
Immunosuppression
28%
Azathioprine
28%
Infectious Disease
14%
Immunosuppressive Drug
14%
Prednisone
14%
Anti-Thymocyte Globulin
14%
Acute Graft Rejection
14%
Survival Rate
14%
Atherosclerosis
14%
Bronchiolitis
14%
Allograft
14%
Infection
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ciclosporin
100%
Azathioprine
28%
Infection
14%
Bronchiolitis Obliterans
14%
Atherosclerosis
14%
Acute Graft Rejection
14%
Immunosuppressive Agent
14%
Survival Rate
14%
Thymocyte Antibody
14%
Postoperative Complication
14%
Prednisone
14%
Hypertension
14%
Biochemistry, Genetics and Molecular Biology
Ciclosporin
100%
Azathioprine
28%
Survival Rate
14%
Anti-Thymocyte Globulin
14%
Prednisone
14%